new guidelines for preventing and treating osteoporosis
January 2003
The Osteoporosis Society of Canada just released new guidelines for preventing and treating osteoporosis.
Bisphosphonates (alendronate, etc) are first-choice drugs for postmenopausal women with low bone mineral density...and for existing osteoporosis in both men and women.
Raloxifene (Evista) is also a first-choice drug for prevention and for treatment of existing osteoporosis in women.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive